Skip to main content
Clinical Trials/NCT04606836
NCT04606836
Unknown
Phase 4

Analyzing the Efficacy of Peri-operative Intercostal Nerve Blocks ICNB for Acute Postoperative Pain Control in Reconstructive Breast Surgery and Mammoplasty

Christine M. Kleinert Institute for Hand and Microsurgery5 sites in 1 country40 target enrollmentDecember 7, 2020

Overview

Phase
Phase 4
Intervention
Bupivacaine Hydrochloride
Conditions
Pain, Postoperative
Sponsor
Christine M. Kleinert Institute for Hand and Microsurgery
Enrollment
40
Locations
5
Primary Endpoint
Post-operative pain
Last Updated
5 years ago

Overview

Brief Summary

The authors will conduct this study to analyze the effectiveness of peri-operative intercostal nerve blocks (ICNBs) in reducing acute postoperative pain after reconstructive breast surgery and mammoplasty and how it affects the length of hospital stay.

Registry
clinicaltrials.gov
Start Date
December 7, 2020
End Date
August 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Christine M. Kleinert Institute for Hand and Microsurgery
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists Classification (ASA Class) 3 and below.
  • Bilateral or unilateral breast surgery including cancer extirpation, reconstruction (implant and expander), oncoplastic surgery (\<200 gm), breast augmentation and breast reduction, etc.

Exclusion Criteria

  • Patients who refuse local anesthesia.
  • Patients who cannot receive local anesthesia.
  • Below the age of 20 and above the age of
  • Patients requiring reoperation due to complications of mammoplasty or another breast surgery.
  • Poorly controlled diabetics, uncontrolled hypertension, heart disease, arrhythmias, diagnosed with bipolar and generalized anxiety disorders.

Arms & Interventions

Prospective Cases

These cases will be recruited prospectively, and receive the intercostal nerve block(s) on operated site(s). Peri-operative injections of 30 ml of 0.25% Bupivacaine each, injected over the 4th, 5th, and 6th ribs on the operated site(s).

Intervention: Bupivacaine Hydrochloride

Outcomes

Primary Outcomes

Post-operative pain

Time Frame: 120 minutes post-operation

Visual Analog Score (VAS) for pain compared between cases and controls, pain score on scale from 0 (no pain) to 10 (worst pain)

Secondary Outcomes

  • Length of Hospital Stay(Through study completion, average of 1 day)

Study Sites (5)

Loading locations...

Similar Trials